A CLINICAL STUDY ON EKAKUSTHA(PSORIASIS) AND IT’S MANAGEMENT BY VAMANA KARMA AFTER TAKING OF PANCHAKOLA & SNEHAPANA

Journal of Bio Innovation Pub Date : 2022-07-30 DOI:10.46344/jbino.2022.v11i03(b).03

P. Mukherjee

{"title":"A CLINICAL STUDY ON EKAKUSTHA(PSORIASIS) AND IT’S MANAGEMENT BY VAMANA KARMA AFTER TAKING OF PANCHAKOLA & SNEHAPANA","authors":"P. Mukherjee","doi":"10.46344/jbino.2022.v11i03(b).03","DOIUrl":null,"url":null,"abstract":"Psoriasis is a non infectious chronic relapsing inflammatory skin diseases characterized by well defined dry scaly erythmatous patches & covered with adherent silvery white scales. Psoriasis can be correlated with “Ekakustha” in Ayurveda .Ekakustha is predominated with Vata & kafa dosa.The symptoms of Ekakustha -Aswedana {not perspire) ,mahavastu(extensive), masyasokolapama(looks like fish scale) and Arun barna(discolouration).In this clinical study 50 patents of psoriasis are selected according to inclusion & exclusion criteria. The total patients have been divided into three groups. Group A has been treated with “Panchakola powder’ (3 gm thrice before meal for 7 days); Group B patents have been treated by ‘Mahatiktak Ghrita”(as scheduled dose of snehapana up to samyak sneha lakshana is appeared 3-7 days);And Group C patients have been treated with Powder Panchakola +Mahatikta ghrita +Vamana karma (by Modan phala powder + Vacha pow +Saindhav lavana along with madhu & Yasthimadhu kwath),After administration of drugs & therapy the percentage of relief of Group A-Matsyasokolapama(55.83%), Rukhsata(53%), Arunattwa(50%), kandu (50%).In Group B patients after application of Panchakola + Mahatiktak Ghrita the percentage of relief Matsyasokolapama(42%), Rukhsata(58%), Arunattwa(42.5%) Kandu(40.82%)..And after administration of Panchakola powder +Mahatikta ghrita + Vamana in Group C patients the percentage of relief –Matsyasokolapama (67.78%) ,Rukshata(64.8%), Arunattwa(65.35%) kandu(72.01%).","PeriodicalId":228982,"journal":{"name":"Journal of Bio Innovation","volume":"16 ","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bio Innovation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46344/jbino.2022.v11i03(b).03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Psoriasis is a non infectious chronic relapsing inflammatory skin diseases characterized by well defined dry scaly erythmatous patches & covered with adherent silvery white scales. Psoriasis can be correlated with “Ekakustha” in Ayurveda .Ekakustha is predominated with Vata & kafa dosa.The symptoms of Ekakustha -Aswedana {not perspire) ,mahavastu(extensive), masyasokolapama(looks like fish scale) and Arun barna(discolouration).In this clinical study 50 patents of psoriasis are selected according to inclusion & exclusion criteria. The total patients have been divided into three groups. Group A has been treated with “Panchakola powder’ (3 gm thrice before meal for 7 days); Group B patents have been treated by ‘Mahatiktak Ghrita”(as scheduled dose of snehapana up to samyak sneha lakshana is appeared 3-7 days);And Group C patients have been treated with Powder Panchakola +Mahatikta ghrita +Vamana karma (by Modan phala powder + Vacha pow +Saindhav lavana along with madhu & Yasthimadhu kwath),After administration of drugs & therapy the percentage of relief of Group A-Matsyasokolapama(55.83%), Rukhsata(53%), Arunattwa(50%), kandu (50%).In Group B patients after application of Panchakola + Mahatiktak Ghrita the percentage of relief Matsyasokolapama(42%), Rukhsata(58%), Arunattwa(42.5%) Kandu(40.82%)..And after administration of Panchakola powder +Mahatikta ghrita + Vamana in Group C patients the percentage of relief –Matsyasokolapama (67.78%) ,Rukshata(64.8%), Arunattwa(65.35%) kandu(72.01%).

查看原文本刊更多论文

服用panchakola和snehapana后治疗银屑病的临床研究

牛皮癣是一种非传染性慢性复发性炎症性皮肤病，其特征是明确的干燥鳞状红斑斑块和覆盖着粘附的银白色鳞片。牛皮癣与阿育吠陀中的“Ekakustha”相关，Ekakustha以Vata和kafa dosa为主。Ekakustha的症状是aswedana(不出汗)、mahavastu(大量)、masyasokolapama(看起来像鱼鳞)和Arun barna(变色)。在本临床研究中，根据纳入和排除标准选择50例牛皮癣患者。所有患者被分为三组。A组患者给予“Panchakola散”(3 gm，餐前3次，连用7 d);B组患者用“maatiktak Ghrita”治疗(按照计划剂量服用snehapana至samyak sneha lakshana 3-7天);C组患者用Panchakola粉末+ maatikta Ghrita +Vamana karma(由Modan phala粉末+ Vacha pow +Saindhav lavana以及madhu和Yasthimadhu kwath)治疗，药物和治疗后，a组患者的缓解百分比为:matsyasokolapama (55.83%)， Rukhsata(53%)， Arunattwa(50%)， kandu(50%)。B组患者应用Panchakola + maatiktak Ghrita后缓解率为:Matsyasokolapama(42%)、Rukhsata(58%)、Arunattwa(42.5%)、Kandu(40.82%)。C组患者经Panchakola散+ maatikta ghrita + Vamana治疗后缓解率为:matsyasokolapama(67.78%)、Rukshata(64.8%)、Arunattwa(65.35%)、kandu(72.01%)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Bio Innovation

自引率

0.00%

发文量